Skip to main content
Premium Trial:

Request an Annual Quote

Nirmidas Closes $2M Funding Round

Premium

NEW YORK (GenomeWeb) – Stanford biosensing spin-out Nirmidas Biotech said this week that it has closed on a $2 million seed funding round.

According to the company, participants in the round include a leading venture capital fund, a life science angel investor, and the Stanford StartX Fund.

Nirmidas is developing a plasmonic gold chip platform for biomolecule detection and the detection of proteins in particular.

The technology comes out of the lab of Stanford researcher Hongjie Dai, who co-founded Nirmidas with CEO Meijie Tang, formerly a researcher at Lawrence Livermore National Laboratory. Currently operating with five employees, the company incorporated in September 2013 and began production of its initial research-focused chips in March this year.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.